💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Epizyme, Inc. (EPZM)
« Back to company indexEPZM Chatter Timeline
Stock Ticker for EPZM
Most Active Tweeters for EPZM
| User | Tweets |
|---|---|
| @Tickeron | 6 |
| @jesper_dpj | 3 |
| @TradeWithAlerts | 3 |
| @ResearchPool | 2 |
| @fintel_io | 2 |
Recent Tweets for EPZM
 |
@stockhoot $EPZM Morgan Stanley Maintains to Equal-Weight : PT $11.00 https://t.co/43HBX8FYXk April 19th 2021, 2:04pm |
 |
@tradersreport RT @Tickeron: $EPZM in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on March 29, 2021. View odds for thi… April 18th 2021, 3:04pm |
 |
@Tickeron $EPZM in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on March 29, 2021. View od… https://t.co/vUxsZ33gKE April 18th 2021, 3:04pm |
 |
@ResearchPool $EPZM #Epizyme Inc ... Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 9: [...]… https://t.co/qcWKJo3ELv April 16th 2021, 1:04pm |
|
@Tickeron $EPZM in -3.56% Downtrend, declining for three consecutive days on April 12, 2021. View odds for this and other ind… https://t.co/iw7Q0RPsLW April 16th 2021, 2:04am |
 |
@fintel_io $EPZM / Epizyme files form PRE 14A https://t.co/BqbuwxVxrV April 15th 2021, 9:04pm |
 |
@jesper_dpj $EPZM how is the partnership project coming along? It is not enough to put it on a PowerPoint slide and just wait by the phone. April 15th 2021, 8:04pm |
 |
@TradeWithAlerts Large Print $EPZM Size: 106044 Price: 8.22 Time: 1600 Amount: $871,681.68 April 14th 2021, 8:04pm |
 |
@FlashAlert_me $EPZM [15s. delayed] filed SEC form 4: Chief Scientific Officer Kutok Jeffery: Disposed 2,029 of Common Stock at p… https://t.co/Jynfbo9oR9 April 14th 2021, 10:04am |
|
@Tickeron $EPZM in -3.56% Downtrend, sliding for three consecutive days on April 12, 2021. View odds for this and other indic… https://t.co/IZABSXmCND April 14th 2021, 4:04am |
|
@TradeWithAlerts Large Print $EPZM Size: 113637 Price: 8.185 Time: 1600 Amount: $930,118.85 April 13th 2021, 8:04pm |
|
@Tickeron $EPZM's price moved below its 50-day Moving Average on January 26, 2021. View odds for this and other indicators:… https://t.co/4QdcmrKNOd April 12th 2021, 11:04pm |
|
@TradeWithAlerts Large Print $EPZM Size: 148832 Price: 8.12 Time: 1600 Amount: $1,208,515.84 April 12th 2021, 8:04pm |
 |
@hadidy_sara $EPZM: Signals could not be any clearer on the 1-minute chart of EPZM. Awaiting Short Signal. https://t.co/l4WVzG53U2 April 12th 2021, 7:04pm |
|
@jesper_dpj @lblegend33 $EPZM holding for the buyout! Or pink sheets ??????? April 11th 2021, 9:04am |
|
@Tickeron $EPZM's price moved below its 50-day Moving Average on January 26, 2021. View odds for this and other indicators:… https://t.co/3X57Ufh3ph April 9th 2021, 8:04pm |
|
@ResearchPool $EPZM #Epizyme Inc ... Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 2: [...]… https://t.co/M9agwOwaXt April 9th 2021, 5:04pm |
 |
@MACDcurlingup Great find @CaesarBiotech $EPZM abstract with exciting clinical data. Phase 2 study of tazemetostat in Japanese pat… https://t.co/uVb3JmiEQm April 9th 2021, 4:04pm |
|
@Tickeron $EPZM in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/AvBNL57pXf April 8th 2021, 6:04pm |
 |
@InsiderForms $EPZM Insider Kutok Jeffery has Sold 2,029 Shares. Title :Chief Scientific Officer Total Cost: $17,855.2 Buy/Sell… https://t.co/I9KoAgfC3i April 7th 2021, 12:04pm |
 |
@StockTexts $EPZM Epizyme, Inc. SEC Filing: Form 4 https://t.co/5bHenIgHQM April 7th 2021, 10:04am |
 |
@insiderbuyings $EPZM new insider selling: 2029 shares. https://t.co/ejfzXXsQTr April 7th 2021, 10:04am |
|
@fintel_io Insider Jeffery Kutok reports selling 2,029 shares of $EPZM for a total cost of $17,855.20 https://t.co/fFToh7hzrE April 7th 2021, 10:04am |
 |
@formwhisperscom #FWSells $EPZM Kutok Jeffery, Chief Scientific Officer of Epizyme, Inc. sold 2,029 shares on 2021-04-05. https://t.co/vRKGmH7nvO April 7th 2021, 10:04am |
|
@jesper_dpj $EPZM never fails to instill you with optimism only to send you and your optimism through the shredder April 6th 2021, 8:04pm |
 |
@Maximus_Holla $EPZM non stop since 52 week low! https://t.co/cl4X39OIZ8 April 5th 2021, 3:04pm |
 |
@tradarina $EPZM on elevator trend +8.34% so far! worth waiting for a couple of months ! April 5th 2021, 2:04pm |
|
@MACDcurlingup $EPZM been on elevator up since insider adds. Trimmed a few here! https://t.co/Pqqp1N8BDt April 5th 2021, 2:04pm |
 |
@YouCanFoolMost RT @Tickeron: $EPZM in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/c7LsdtWt03 #Epizym… April 5th 2021, 3:04am |
|
@Tickeron $EPZM in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/isS0ZzzzyU April 5th 2021, 3:04am |
|
@Tickeron $EPZM in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/I8Fh9hSgX0 April 4th 2021, 8:04am |
 |
@ChartMill $EPZM: Comparing the growth rate of the last 5 years to the rate of the upcoming 2 years, we see that the growt ...… https://t.co/FuJDJWkHFV April 3rd 2021, 5:04pm |
|
@Tickeron $EPZM in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/shw4hIVeC6 April 3rd 2021, 5:04am |
 |
@newsfilterio $23,752.17 of shares acquired by Mott David M (Director), reported in a new form 4 filed with the SEC $EPZM https://t.co/UrpDOcA9d0 April 2nd 2021, 10:04am |
|
@newsfilterio $15,007.33 of shares acquired by Conroy Kevin T (Director), reported in a new form 4 filed with the SEC $EPZM https://t.co/8VqAOqUPBK April 2nd 2021, 9:04am |
 |
@InsiderAlerts4U $EPZM: New Insider Filing on Epizyme, Inc.'s Director DAVID M MOTT: https://t.co/TyfOK8cmMT April 2nd 2021, 2:04am |
|
@InsiderAlerts4U $EPZM: New Insider Filing on Epizyme, Inc.'s Director KEVIN T CONROY: https://t.co/klsmbAqmlo April 2nd 2021, 12:04am |
|
@FlashAlert_me $EPZM [15s. delayed] filed SEC form 4: Director MOTT DAVID M: Granted 2,727 of Common Stock at price $8.71 on 2021… https://t.co/2p64Aq3Mog April 1st 2021, 11:04pm |
|
@TradeWithAlerts Large Print $EPZM Size: 111239 Price: 8.63 Time: 1600 Amount: $959,992.57 April 1st 2021, 8:04pm |
 |
@intratio $EPZM https://t.co/bb0WcYkoOb Epizyme Inc Our model foresees this equity value will shortly go down and is facing s… https://t.co/2fhIQ5M4eo April 1st 2021, 5:04pm |
 |
@MarcJacksonLA $EPZM $VRCA 2 Strong Buy Stocks Insiders Are Snapping Up https://t.co/rKbStg52eT April 1st 2021, 5:04pm |
 |
@TipRanks 2 “Strong Buy” Stocks Insiders Are Snapping Up https://t.co/Ax859CT0Xt $EPZM $VRCA April 1st 2021, 4:04pm |
 |
@be4_the_herd $EPZM Credit Suisse Starts Epizyme at Outperform with $13 Price Target April 1st 2021, 12:04pm |
 |
@nolastevedore @egelandd Epigenetics, which $EPZM dabbles in, seems (to me) like it is either an under-recognized area of cancer r… https://t.co/s1Rk8IlZOn April 1st 2021, 12:04am |
 |
@egelandd $epzm 7.50 to 8.70 in 2 days- what’s changed? Mkt realizing there r commercial stage bios w/approved products, plen… https://t.co/uDgv6FixmQ March 31st 2021, 8:03pm |
|
@MarcJacksonLA $EPZM Credit Suisse Starts Coverage On Epizyme With An Outperform Rating, $13 PT https://t.co/W5XdaQhyqU March 31st 2021, 8:03pm |
 |
@AlertTrade REVERSALtoUP: $EPZM Epizyme, Inc https://t.co/ATByFX9OZZ ? ? TradeIdeas via ? https://t.co/ZgCyz4rX3x March 31st 2021, 5:03pm |
|
@egelandd An insider buys some $epzm so now all the bio chasing experts suddenly love it. Added huge at 7.50- be better than… https://t.co/pc3wvoGVRr March 31st 2021, 12:03pm |
|
@stockhoot $EPZM Credit Suisse Initiates Coverage On to Outperform : PT $13.00 https://t.co/jzwUdp6Ny8 March 31st 2021, 11:03am |
|
@Tickeron $EPZM's price moved below its 50-day Moving Average on January 26, 2021. View odds for this and other indicators:… https://t.co/CdjY0OhnTR March 31st 2021, 4:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
